Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections).


Journal

Current rheumatology reports
ISSN: 1534-6307
Titre abrégé: Curr Rheumatol Rep
Pays: United States
ID NLM: 100888970

Informations de publication

Date de publication:
16 07 2021
Historique:
accepted: 25 05 2021
entrez: 16 7 2021
pubmed: 17 7 2021
medline: 24 7 2021
Statut: epublish

Résumé

We reviewed the current data on infections associated with rituximab use published over the last 5 years. New literature was available on rates of serious infections, Hepatitis B reactivation and screening, and infection with Severe Acute Respiratory Syndrome Coronavirus 2. Rates of infection varied by study and population, however, higher risk of infection in patients with underlying rheumatologic diseases was seen in those who required a therapy switch, had a smoking history, and those undergoing retreatment who had a serious infection with their first course of therapy. With regards to HBV, the proportion of patients screened continues to be inadequate. Despite the upfront cost, HBV screening and prophylaxis were found to be cost effective. There is still limited data regarding COVID-19 severity in the setting of rituximab, however, rituximab, especially in combination with steroids, may lead to more severe disease and higher mortality.

Identifiants

pubmed: 34269903
doi: 10.1007/s11926-021-01037-3
pii: 10.1007/s11926-021-01037-3
pmc: PMC8284038
doi:

Substances chimiques

Antirheumatic Agents 0
Antiviral Agents 0
Rituximab 4F4X42SYQ6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

74

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1172-8
pubmed: 27388147
Rheum Dis Clin North Am. 2017 Feb;43(1):1-13
pubmed: 27890167
Arthritis Care Res (Hoboken). 2018 Oct 8;:
pubmed: 30295434
Ann Rheum Dis. 2020 Dec;79(12):1659-1661
pubmed: 32606046
Ann Rheum Dis. 2020 Jul;79(7):988-990
pubmed: 32503857
BMC Neurol. 2021 May 1;21(1):183
pubmed: 33933026
Medicine (Baltimore). 2017 Mar;96(13):e6528
pubmed: 28353614
Rev Esp Enferm Dig. 2017 Sep;109(9):619-626
pubmed: 28648087
Am J Gastroenterol. 2016 Dec;111(12):1788-1795
pubmed: 27644733
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
Mult Scler Relat Disord. 2020 Jul;42:102185
pubmed: 32408147
Ann Rheum Dis. 2019 Mar;78(3):320-327
pubmed: 30612115
Rheumatol Int. 2019 Jun;39(6):1083-1090
pubmed: 30923955
Br J Haematol. 2020 Jul;190(2):185-188
pubmed: 32557623
Ann Rheum Dis. 2021 May;80(5):e67
pubmed: 32591357
Medicine (Baltimore). 2016 Mar;95(11):e3064
pubmed: 26986131
Ann Clin Transl Neurol. 2021 Apr;8(4):938-943
pubmed: 33783140
J Am Acad Dermatol. 2021 Apr;84(4):e197-e198
pubmed: 33130180
Clin Rheumatol. 2017 Dec;36(12):2743-2750
pubmed: 28980088
Rheumatol Int. 2020 Dec;40(12):2015-2021
pubmed: 32945944
Ann Rheum Dis. 2021 Mar 23;:
pubmed: 33757968
Ann Rheum Dis. 2021 Jan;80(1):e10
pubmed: 32312768
Clin Infect Dis. 2022 Jan 7;74(1):59-65
pubmed: 33704435
Ann Rheum Dis. 2020 Dec;79(12):1544-1549
pubmed: 32796045
Dig Dis Sci. 2019 Oct;64(10):2992-3000
pubmed: 30982209
World J Gastroenterol. 2016 Jul 28;22(28):6484-500
pubmed: 27605883
Rheumatology (Oxford). 2018 Mar 1;57(3):538-547
pubmed: 29267905
Ann Rheum Dis. 2021 Mar 4;:
pubmed: 33674264
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
N Engl J Med. 2020 Jul 2;383(1):85-88
pubmed: 32348641
Dig Dis Sci. 2016 Aug;61(8):2236-2241
pubmed: 26993822
Rheumatology (Oxford). 2020 Aug 1;59(8):1949-1956
pubmed: 31764977
J Neurol. 2021 Jan;268(1):5-7
pubmed: 32654064
World J Gastroenterol. 2016 May 21;22(19):4732-40
pubmed: 27217704
Arthritis Rheumatol. 2019 Nov;71(11):1812-1823
pubmed: 31131994
Hepatology. 2018 Apr;67(4):1560-1599
pubmed: 29405329
Nephrol Dial Transplant. 2017 Apr 1;32(4):722-729
pubmed: 28339910
Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101663
pubmed: 33536145
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):925-929
pubmed: 29621049
Semin Arthritis Rheum. 2020 Oct;50(5):1087-1088
pubmed: 32916559
Ann Rheum Dis. 2021 Jul;80(7):930-942
pubmed: 33504483

Auteurs

Cara D Varley (CD)

Oregon Health & Science University-Portland State University School of Public Health, Portland, OR, United States. varleyc@ohsu.edu.
Oregon Health & Science University, School of Medicine, Division of Infectious Diseases, 3181 SW Sam Jackson Park Rd, Mail Code L-457, Portland, OR, 97239, United States. varleyc@ohsu.edu.

Kevin L Winthrop (KL)

Oregon Health & Science University, School of Medicine, Division of Infectious Diseases, 3181 SW Sam Jackson Park Rd, Mail Code L-457, Portland, OR, 97239, United States.
Oregon Health & Science University, School of Medicine, Division of Infectious Diseases, Ophthalmology, 181 SW Sam Jackson Park Rd, Mail Code GH104, Portland, OR, 97239, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH